Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Genetics of Developmental Disorders
-
1. Imprinting disorders associated with molecular changes on chromosome 11p15
- Prof. Rosanna Weksberg
-
2. Chromatin genes and disease
- Prof. Richard Gibbons
-
3. Heterochromatin, epigenetics and gene expression
- Prof. Joel C. Eissenberg
- Cardiopulmonary Disease
-
4. Transcription factors and complex disease development
- Dr. Ines Pineda-Torra
-
5. Molecular genetics of pulmonary arterial hypertension
- Prof. Richard C. Trembath
- Neuromuscular System Diseases
-
6. Gene therapy for the muscular dystrophies
- Prof. Jeff Chamberlain
-
7. RAS pathway and disease: neurofibromatosis and beyond
- Prof. Eric Legius
-
8. Congenital syndromes of pain and painlessness
- Prof. Geoff Woods
- Prof. James Cox
- Endocrinology and Metabolism
-
9. Changing lives: stratified medicine in monogenic diabetes
- Prof. Andrew Hattersley
-
10. Genetics of monogenic obesity 1
- Prof. Dr. Johannes Hebebrand
- Prof. Dr. Anke Hinney
-
11. Genetics of monogenic obesity 2
- Prof. Dr. Johannes Hebebrand
- Prof. Dr. Anke Hinney
- Cancer Genetics
-
13. Inherited predisposition to breast cancer
- Prof. Diana Eccles
-
14. Genetics of breast and ovarian cancer
- Prof. Jeffrey Weitzel
-
16. NF2-related Schwannomatosis and Gorlin Syndrome
- Prof. D. Gareth R. Evans
-
17. The genetic basis of kidney cancer
- Dr. W. Marston Linehan
- Oligogenic and Complex Diseases
-
18. Ciliopathies and oligogenic phenomena
- Prof. Nicholas Katsanis
- Therapy
-
19. Mismatch repair deficient cancers & Lynch syndrome
- Prof. Sir John Burn
- Archived Lectures *These may not cover the latest advances in the field
-
20. Mismatch repair deficient cancers: diagnosis, treatment and prevention
- Prof. Sir John Burn
-
21. NF2 & Gorlins
- Prof. D. Gareth R. Evans
Printable Handouts
Navigable Slide Index
- Introduction
- Some key questions in human genetics
- The 'rules' of pathogenicity
- Modification of rules for oligogenic traits
- Preconceived notions of disease inheritance
- Example: motor neuron disease (ALS)
- ALS - pedigree of one family
- Models of oligogenicity - direct\indirect complex
- Pathway rescue model
- Converging pathway model
- Moving on from theory to real time examples
- Oligogenic architecture - Bardet-Biedl syndrome
- BBS and variable penetrance
- BBS and variable expressivity
- Linking BBS to ciliary dysfunction
- Cilia - implicated in several genetic disorders
- Understanding penetrance and expressivity
- Depletion of ciliary proteins perturbs PCP
- Ciliary biology-hypothesis, challenge, major benefit
- Assessing pathogenicity of human mutations
- Assessing pathogenicity of missense variants
- Deciphering causality of patient mutations
- Mapping it all back to humans
- Applying these lessons to the ciliary proteome
- Probing total mutational load in ciliopathy patients
- IFT139 as a panciliopathy contributor
- IFT139/TTC21B - novel variants unique to patients
- Most IFT139 missense variants are pathogenic
- Pathogenic alleles in cases and controls
- Mutations in IFT139 cause JATD and NPHP
- Pathogenic alleles enriched in ciliopathy cases
- Dissection of a functional ciliary module
- 312 coding nonsynonymous variants: a challenge
- Causality under a 'recessive' model
- Mapping alleles back to patients: IFT complex A
- Locus contribution - functional study necessary
- Context matters
- Thanks
- Acknowledgments
Topics Covered
- Ciliopathies: multisystemic disorders caused by structural and/or functional defects of the primary cilium
- Mutations in almost 100 genes discovered to date, no clear pattern between specific genes and specific phenotypes
- Functional interpretation of variants critical for understanding the contribution of alleles to disease severity and pleiotropy
- A systems-based consideration for the total amount of pathogenic variation in the ciliary proteome begins to predict clinical substructure
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Katsanis, N. (2015, January 19). Ciliopathies and oligogenic phenomena [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/MTOY7074.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Nicholas Katsanis has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
A selection of talks on Cell Biology
Transcript
Please wait while the transcript is being prepared...
0:00
Hello, everybody.
My name is Nicholas Katsanis.
I am the director for the Center
for Human Disease Modeling at Duke
University and I am a
professor in the Department
of Cell Biology and Pediatrics.
My interests focus on how does
the genotype match the phenotype
in humans and how can you use
a mixture of technologies,
such as sequencing and
implementation of model organisms,
to understand causality
in human genetic disease
and complex genetic interactions?
Today, I will be giving a lecture
that is focused on ciliopathies
and the lessons that we've
learned in oligogenic phenomena
during our journey.
0:36
Before I begin, I really thought
I should highlight some questions
that have really persisted
during the last hundred years,
truly since the discovery
of Mendel's laws.
If we think fundamentally
about the types of questions
that we're all trying to
investigate, while in the old days,
we used to use things like
karyotyping, in the modern days,
we try to address these
problems with next generation
sequencing and tools of that sort.
Nonetheless, the questions have
remained fundamentally the same.
The first question is what
variants cause disease?
And of course, we're
dealing with humans,
but the question naturally applies
to all model organisms as well.
It is fair to say that we
have made significant, rather
impressive progress in that regard.
We have identified thousands of
alleles in thousands of genes that
are associated causally with both
common and rare genetic disorders.
However, there's a
second question here,
and this question is,
what variants might
be associated with
disease modulation?
That question is both
harder and has proven
to be more difficult
to track experimentally
for a number of
reasons, some of which
I will highlight later in my talk.
And of course, the
subtext of all this
is, is there a difference
between alleles that appear
to be genetically sufficient
to cause a disease
and alleles that appear
to confer susceptibility,
or interaction, or epistasis,
or some of these perhaps used
to be exotic phenomena
in human genetics?
So the fundamental question
underneath all of this
is, we have always tried
to understand the effect
of a single allele on a
single gene in a vacuum.
However, it is important that
we remember that the presence
of rare alleles highly
directly resembles,
and the context, of course,
is going to be important,
but everything occurs in the
context and in the backdrop
of the entire genome, the epigenome,
and of course the environment.
Indeed, one of the greatest
difficulties that we have
at the moment is we cannot
really discern context-dependent
effect of alleles on the phenotype.